<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="rws" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">rws</book-part-id>
      <title-group>
        <title>Long QT Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alders</surname>
            <given-names>Mari&#x000eb;lle</given-names>
          </name>
          <degrees>PhD</degrees>
          <email>m.alders@amc.uva.nl</email>
          <aff>Department of Clinical Genetics<break/>Academic Medical Center<break/>University of Amsterdam<break/>Amsterdam, The Netherlands</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Christiaans</surname>
            <given-names>Imke</given-names>
          </name>
          <degrees>PhD, MD</degrees>
          <email>i.christiaans@amc.uva.nl</email>
          <aff>Department of Clinical Genetics<break/>Academic Medical Center<break/>University of Amsterdam<break/>Amsterdam, The Netherlands</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2003-02-20" date-type="created">
          <day>20</day>
          <month>2</month>
          <year>2003</year>
        </date>
        <date iso-8601-date="2015-06-18" date-type="updated">
          <day>18</day>
          <month>6</month>
          <year>2015</year>
        </date>
        <date iso-8601-date="2009-08-04" date-type="revised">
          <day>4</day>
          <month>8</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="loeys-dietz" document-type="chapter">Loeys-Dietz Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="lowe" document-type="chapter">Lowe Syndrome</related-object>
      <abstract id="rws.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the ECG and the ventricular tachycardia <italic toggle="yes">torsade de pointes</italic> (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Syncope typically occurs during exercise and high emotions, less frequently at rest or during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal spells. While cardiac events may occur from infancy through middle age, they are most common from the pre-teen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7), hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8) and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis of LQTS is established by prolongation of the QTc interval in the absence of specific conditions known to lengthen it (for example, QT-prolonging drugs) and/or by molecular genetic testing that identifies a diagnostic change (or changes) in one or more of the 15 genes known to be associated with LQTS, of which <italic toggle="yes">KCNQ1</italic> (locus name LQT1), <italic toggle="yes">KCNH2</italic> (LQT2) and <italic toggle="yes">SCN5A</italic> (LQT3) are the most common. Other, less frequently involved genes are <italic toggle="yes">ANK2</italic> (LQT4), <italic toggle="yes">KCNE1</italic> (LQT5), <italic toggle="yes">KCNE2</italic> (LQT6), <italic toggle="yes">KCNJ2</italic> (LQT7), <italic toggle="yes">CACNA1C</italic> (LQT8), <italic toggle="yes">CAV3</italic> (LQT9), <italic toggle="yes">SCN4B</italic> (LQT10), <italic toggle="yes">AKAP9</italic> (LQT11), <italic toggle="yes">SNTA1</italic> (LQT12), <italic toggle="yes">KCNJ5</italic> (LQT13), <italic toggle="yes">CALM1</italic> (LQT14), and <italic toggle="yes">CALM2</italic> (LQT15). Approximately 20% of families meeting clinical diagnostic criteria for LQTS do not have detectable pathogenic variants in one of the above genes. LQTS associated with biallelic pathogenic variants or heterozygosity for pathogenic variants in two different genes (i.e., digenic pathogenic variants) is generally associated with a more severe phenotype with longer QTc interval and a higher incidence of cardiac events.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Beta-blocker medication is the primary treatment for LQTS; possible implantable cardioverter-defibrillators (ICD) and/or left cardiac sympathetic denervation (LCSD) for those with beta-blocker-resistant symptoms, inability to take beta blockers, and/or history of cardiac arrest. Sodium channel blockers can be useful as additional pharmacologic therapy for patients with a QTc interval &#x0003e;500 ms.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Beta blockers are clinically indicated in all asymptomatic individuals meeting diagnostic criteria, including those who have a pathogenic variant on molecular testing and a normal QTc interval. In general, ICD implantation is not indicated for individuals with LQTS who are asymptomatic and who have not been tried on beta blocker therapy. Prophylactic ICD therapy can be considered for individuals with LQTS who are asymptomatic but suspected to be at very high risk (e.g., those with &#x02265;2 pathogenic variants on molecular testing).</p>
          <p><italic toggle="yes">Surveillance:</italic> Regular assessment of beta-blocker dose for efficacy and adverse effects in all individuals with LQTS, especially children during rapid growth; regular periodic evaluations of ICDs for inappropriate shocks and pocket or lead complications.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Drugs that cause further prolongation of the QT interval or provoke <italic toggle="yes">torsade de pointes</italic>; competitive sports/activities associated with intense physical activity and/or emotional stress for most individuals.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Presymptomatic diagnosis and treatment is warranted in relatives at risk to prevent syncope and sudden death.</p>
          <p><italic toggle="yes">Other:</italic> For some individuals, availability of automatic external defibrillators at home, at school, and in play areas.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>LQTS is typically inherited in an autosomal dominant manner. An exception is LQTS associated with sensorineural deafness (known as Jervell and Lange-Nielsen syndrome), which is inherited in an autosomal recessive manner. Most individuals diagnosed with LQTS have an affected parent. The proportion of LQTS caused by a <italic toggle="yes">de novo</italic> pathogenic variant is small. Each child of an individual with autosomal dominant LQTS has a 50% risk of inheriting the pathogenic variant. Penetrance of the disorder may vary. Prenatal testing for pregnancies at increased risk and preimplantation genetic diagnosis are possible once the pathogenic variant(s) have been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="rws.Diagnosis">
        <title>Diagnosis</title>
        <sec id="rws.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Long QT syndrome (LQTS) should be suspected in individuals on the basis of ECG characteristics, clinical presentation, and family history.</p>
          <p>
            <bold>ECG evaluation</bold>
          </p>
          <p><bold>Corrected QT (QTc) values on resting ECG.</bold> The QTc on resting ECG is neither completely sensitive nor specific for the diagnosis of LQTS. Approximately 25% of individuals with LQTS confirmed by the identification of a pathogenic variant in a LQTS-associated gene may have a normal range QTc (concealed LQTS) [<xref ref-type="bibr" rid="rws.REF.goldenberg.2011.51">Goldenberg et al 2011</xref>]. Also, there are several other factors that can lengthen the QTc interval :</p>
          <list list-type="bullet">
            <list-item>
              <p>QT-prolonging drugs</p>
            </list-item>
            <list-item>
              <p>Hypokalemia</p>
            </list-item>
            <list-item>
              <p>Certain neurologic conditions including subarachnoid bleed</p>
            </list-item>
            <list-item>
              <p>Structural heart disease</p>
            </list-item>
          </list>
          <p>The following tests are helpful for further evaluation of individuals with "uncertain" QTc values on resting ECG:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Exercise ECG,</bold> which commonly shows failure of the QTc to shorten normally and even prolongation of the QTc interval [<xref ref-type="bibr" rid="rws.REF.jervell.1957.59">Jervell &#x00026; Lange-Nielsen 1957</xref>, <xref ref-type="bibr" rid="rws.REF.vincent.1991.498">Vincent et al 1991</xref>, <xref ref-type="bibr" rid="rws.REF.swan.1998.508">Swan et al 1998</xref>, <xref ref-type="bibr" rid="rws.REF.horner.2011.1698">Horner et al 2011</xref>, <xref ref-type="bibr" rid="rws.REF.sy.2011.2187">Sy et al 2011</xref>]. Many individuals develop characteristic T-wave abnormalities [<xref ref-type="bibr" rid="rws.REF.zhang.2000.2849">Zhang et al 2000</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>QTc interval measurement</bold> during change from supine to standing position [<xref ref-type="bibr" rid="rws.REF.viskin.2010.1955">Viskin et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Intravenous pharmacologic provocation</bold>
<bold>testing</bold> (e.g., with epinephrine), which may be helpful by demonstrating inappropriate prolongation of the QTc interval [<xref ref-type="bibr" rid="rws.REF.ackerman.2002.413">Ackerman et al 2002</xref>]. With the small risk of induction of arrhythmia, such provocative testing is best performed in laboratories experienced in arrhythmia induction and control [<xref ref-type="bibr" rid="rws.REF.shimizu.2004.276">Shimizu et al 2004</xref>, <xref ref-type="bibr" rid="rws.REF.vyas.2006.1385">Vyas et al 2006</xref>].</p>
            </list-item>
          </list>
          <p><bold>Clinical history.</bold> A personal history of syncope, aborted cardiac arrest, or sudden death in a child or young adult may lead to suspicion of LQTS. The syncope is typically precipitous and without warning, thus differing from the common vasovagal and orthostatic forms of syncope in which presyncope and other warning symptoms occur. Absence of aura, incontinence, and postictal findings help differentiate LQTS-associated syncope from seizures.</p>
          <p><bold>Family history.</bold> A family history of syncope, aborted cardiac arrest, or sudden death in a child or young adult and consistent with autosomal dominant inheritance or autosomal recessive inheritance supports the diagnosis of LQTS.</p>
        </sec>
        <sec id="rws.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p><xref ref-type="bibr" rid="rws.REF.schwartz.1993.782">Schwartz et al [1993]</xref> proposed a scoring system to diagnose LQTS on a clinical basis; it was updated by <xref ref-type="bibr" rid="rws.REF.schwartz.2011.2181">Schwartz &#x00026; Crotti [2011]</xref>. Points are assigned to various criteria (see <xref ref-type="table" rid="rws.T.scoring_system_for_clinical_diagno">Table 1</xref>).</p>
          <table-wrap id="rws.T.scoring_system_for_clinical_diagno" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Scoring System for Clinical Diagnosis of Long QT Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">Findings</th>
                  <th id="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Points</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="8" valign="middle" align="left" scope="row" colspan="1">
                    <bold>ECG&#x000a0;<sup>1</sup></bold>
                  </td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="4" valign="middle" align="left" colspan="1">QTc&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">&#x02265;480 ms</td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">=460-479 ms</td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">=450-459 ms (in males)</td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">&#x02265;480 ms during 4<sup>th</sup> minute of recovery from exercise stress test</td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1"><italic toggle="yes">Torsade de pointes</italic>&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">T wave alternans</td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Notched T wave in 3 leads</td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Low heart rate for age&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0.5</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Clinical <break/>history</bold>
                  </td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="2" valign="middle" align="left" colspan="1">Syncope&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">With stress</td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Without stress</td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Family <break/>history</bold>
                  </td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="2" align="left" rowspan="1">Family member(s) with definite LQTS&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Unexplained sudden cardiac death before age 30 years among immediate family&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0.5</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" valign="middle" colspan="3" align="left" scope="col" rowspan="1">
                    <bold>Total score</bold>
                  </td>
                  <td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Adapted from <xref ref-type="bibr" rid="rws.REF.schwartz.2011.2181">Schwartz &#x00026; Crotti [2011]</xref></p>
              </fn>
              <fn>
                <p>Scoring:</p>
              </fn>
              <fn>
                <p>&#x02264;1.0 point = low probability of LQTS</p>
              </fn>
              <fn>
                <p>1.5-3.0 points = intermediate probability of LQTS</p>
              </fn>
              <fn>
                <p>&#x02265;3.5 points = high probability of LQTS</p>
              </fn>
              <fn>
                <p>Footnotes:</p>
              </fn>
              <fn id="rws.TF.1.1">
                <label>1. </label>
                <p>In the absence of medications or disorders known to affect these electrocardiographic features</p>
              </fn>
              <fn id="rws.TF.1.2">
                <label>2. </label>
                <p>QTc (corrected QT) calculated by Bazett&#x02019;s formula where QTc = QT/&#x0221a;RR</p>
              </fn>
              <fn id="rws.TF.1.3">
                <label>3. </label>
                <p>Mutually exclusive</p>
              </fn>
              <fn id="rws.TF.1.4">
                <label>4. </label>
                <p>Resting heart rate &#x0003c;2nd percentile for age</p>
              </fn>
              <fn id="rws.TF.1.5">
                <label>5. </label>
                <p>The same family member cannot be counted for both criteria.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>The diagnosis of LQTS is established in a proband</bold> with one or more of the following [<xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>A risk score of &#x02265;3.5 (see <xref ref-type="table" rid="rws.T.scoring_system_for_clinical_diagno">Table 1</xref>) in the absence of a secondary cause for QT prolongation</p>
            </list-item>
            <list-item>
              <p>The presence of a corrected QT interval &#x02265;500 ms in repeated ECGs in the absence of a secondary cause for QT prolongation</p>
            </list-item>
            <list-item>
              <p>The identification of a pathogenic variant in one of the 15 genes in which mutation causes LQTS</p>
            </list-item>
          </list>
          <p><bold>Molecular testing approaches</bold> may include:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene</bold> molecular genetic testing based on the individual&#x02019;s phenotype (T-wave pattern and triggers of syncope), which has been shown to predict the genotype [<xref ref-type="bibr" rid="rws.REF.zhang.2000.2849">Zhang et al 2000</xref>, <xref ref-type="bibr" rid="rws.REF.van_langen.2003.141">Van Langen et al 2003</xref>] (see <xref ref-type="table" rid="rws.T.genotypephenotype_correlations">Table 3</xref>);Note: Pathogenic variants in <italic toggle="yes">KCNQ1</italic>, <italic toggle="yes">KCNH2</italic>, and <italic toggle="yes">SCN5A</italic> represent the most common causes of LQTS, accounting for 60%-75% of cases (see <xref ref-type="table" rid="rws.T.genes_mutated_in__1_of_individuals">Table 2a</xref>). Pathogenic variants in other LQTS-associated genes are rarely found (see <xref ref-type="table" rid="rws.T.genes_mutated_in__1_of_individuals_1">Table 2b</xref>).</p>
            </list-item>
            <list-item>
              <p>Use of a <bold>multi-gene panel</bold> that includes all LQTS-associated genes and other genes of interest (see <xref ref-type="sec" rid="rws.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <p>In either approach, sequence analysis is performed first; it may be followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found.</p>
          <p>Note: In about 4%-10% of individuals with LQTS, two pathogenic variants are found (digenic/biallelic inheritance). These individuals have a more severe phenotype compared to those with one pathogenic variation with a longer QT interval, a younger age of onset of events, and a higher risk of events [<xref ref-type="bibr" rid="rws.REF.schwartz.2003.1120">Schwartz et al 2003</xref>, <xref ref-type="bibr" rid="rws.REF.westenskow.2004.1834">Westenskow et al 2004</xref>, <xref ref-type="bibr" rid="rws.REF.tester.2005.507">Tester et al 2005</xref>, <xref ref-type="bibr" rid="rws.REF.itoh.2010.1411">Itoh et al 2010</xref>]. Although there is considerable overlap in phenotypic characteristics between those with monogenic and digenic/biallelic pathogenic variants, one could consider sequencing of additional genes in cases with an extreme phenotype.</p>
          <table-wrap id="rws.T.genes_mutated_in__1_of_individuals" position="anchor" orientation="portrait">
            <label>Table 2a. </label>
            <caption>
              <p>Genes Mutated in &#x0003e;1% of Individuals with Long QT Syndrome (LQTS)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_2">Disease Name</th>
                  <th id="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_3">% of LQTS Attributed to Mutation of This Gene&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Reported Pathogenic Variants&#x000a0;<sup>3</sup> Detected by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_4" id="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup></th>
                  <th headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_4" id="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNQ1</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">LQTS type 1&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">30%-35%</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_4 hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">97%-98%</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_4 hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_2_2" rowspan="2" valign="middle" align="left" colspan="1">2%-3%&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNH2</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">LQTS type 2</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">25%-30%</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_4 hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">97%-98%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SCN5A</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">LQTS type 3</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5%-10%</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_4 hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">All variants reported to date</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_4 hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported&#x000a0;<sup>8</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="rws.TF.2a.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="rws" object-id="rws.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="rws.TF.2a.2">
                <label>2. </label>
                <p>Proportion of LQTS caused by a pathogenic variant in each gene is based on <xref ref-type="bibr" rid="rws.REF.splawski.2000.1178">Splawski et al [2000]</xref>, <xref ref-type="bibr" rid="rws.REF.napolitano.2005.2975">Napolitano et al [2005]</xref>, <xref ref-type="bibr" rid="rws.REF.tester.2005.507">Tester et al [2005]</xref>, <xref ref-type="bibr" rid="rws.REF.kapa.2009.1752">Kapa et al [2009]</xref>, <xref ref-type="bibr" rid="rws.REF.kapplinger.2009.1297">Kapplinger et al [2009]</xref>.</p>
              </fn>
              <fn id="rws.TF.2a.3">
                <label>3. </label>
                <p>See <xref ref-type="sec" rid="rws.Molecular_Genetics">Molecular Genetics</xref> for information on pathogenic allelic variants detected.</p>
              </fn>
              <fn id="rws.TF.2a.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="rws.TF.2a.5">
                <label>5. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="rws.TF.2a.6">
                <label>6. </label>
                <p>Biallelic pathogenic variants in <italic toggle="yes">KCNQ1</italic> are associated with <related-object link-type="booklink" source-id="gene" document-id="jln" document-type="chapter">Jervell and Lange-Nielsen syndrome</related-object>.</p>
              </fn>
              <fn id="rws.TF.2a.7">
                <label>7. </label>
                <p>Deletions or duplications involving <italic toggle="yes">KCNQ1 or KCNH2</italic> have been shown to be causal for LQTS in ~3% of cases [<xref ref-type="bibr" rid="rws.REF.barc.2011.40">Barc et al 2011</xref>].</p>
              </fn>
              <fn id="rws.TF.2a.8">
                <label>8. </label>
                <p>The pathogenic variants in <italic toggle="yes">SCN5A</italic> that cause LQTS are due to pathogenic gain-of-function variants (loss-of-function variants of <italic toggle="yes">SCN5A</italic> cause <related-object link-type="booklink" source-id="gene" document-id="brugada" document-type="chapter">Brugada syndrome</related-object>). Therefore, it is highly unlikely that large deletions or duplications in <italic toggle="yes">SCN5A</italic> will be identified as a cause of LQTS.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="rws.T.genes_mutated_in__1_of_individuals_1" position="anchor" orientation="portrait">
            <label>Table 2b. </label>
            <caption>
              <p>Genes Mutated in &#x02264;1% of Individuals with Long QT Syndrome (LQTS)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">
                    <bold>Disease Name</bold>
                  </th>
                  <th id="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <bold>Comment</bold>
                  </th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ANK2</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 4</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNE1</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 5&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNE2</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 6</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNJ2</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 7&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CACNA1C</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 8&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CAV3</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 9</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SCN4B</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 10</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Rare (2 cases)</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">AKAP9</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 11</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">Rare (1 case)</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SNTA1</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 12</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">Rare (3 cases)</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNJ5</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 13</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">Rare (2 cases)</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CALM1</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 14</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CALM2</italic>
                  </td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">LQTS type 15</td>
                  <td headers="hd_h_rws.T.genes_mutated_in__1_of_individuals_1_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="rws.TF.2b.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="rws" object-id="rws.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="rws.TF.2b.2">
                <label>2. </label>
                <p>Biallelic pathogenic variants in <italic toggle="yes">KCNE1</italic> are associated with <related-object link-type="booklink" source-id="gene" document-id="jln" document-type="chapter">Jervell and Lange-Nielsen syndrome</related-object>.</p>
              </fn>
              <fn id="rws.TF.2b.3">
                <label>3. </label>
                <p>LQTS type 7 is also referred to as <related-object link-type="booklink" source-id="gene" document-id="acpp" document-type="chapter">Andersen-Tawil syndrome</related-object>.</p>
              </fn>
              <fn id="rws.TF.2b.4">
                <label>4. </label>
                <p>LQTS type 8 is also referred to as <related-object link-type="booklink" source-id="gene" document-id="timothy" document-type="chapter">Timothy syndrome</related-object>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Note: Approximately 20% of families with a clinically firm diagnosis of LQTS do not have a detectable pathogenic variant in one of the fifteen genes (<italic toggle="yes">KCNQ1</italic>, <italic toggle="yes">KCNH2</italic>, <italic toggle="yes">SCN5A</italic>, <italic toggle="yes">ANK2</italic>, <italic toggle="yes">KCNE1</italic>, <italic toggle="yes">KCNE2</italic>, <italic toggle="yes">CAV3</italic>, <italic toggle="yes">KCNJ2</italic>, <italic toggle="yes">CACNA1C</italic>, <italic toggle="yes">SCN4B</italic>, <italic toggle="yes">AKAP9</italic>, <italic toggle="yes">SNTA1</italic>, <italic toggle="yes">KCNJ5, CALM1</italic>, and <italic toggle="yes">CALM2</italic>) known to be associated with LQTS, suggesting that pathogenic variants in other genes can also cause LQTS and/or that current test methods do not detect all pathogenic variants in the known genes.</p>
        </sec>
      </sec>
      <sec id="rws.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="rws.Clinical_Description">
          <title>Clinical Description</title>
          <p>Long QT syndrome (LQTS) is characterized by QT prolongation and T-wave abnormalities on ECG that are associated with tachyarrhythmias, typically the ventricular tachycardia <italic toggle="yes">torsade de pointes</italic> (TdP). TdP is usually self-terminating, thus causing syncope, the most common symptom in individuals with LQTS. Syncope is typically precipitous and without warning. In some instances, TdP degenerates to ventricular fibrillation and aborted cardiac arrest (if the individual is defibrillated) or sudden death.</p>
          <p>Approximately 50% or fewer of untreated individuals with a pathogenic variant in one of the fifteen genes (see <xref ref-type="table" rid="rws.T.genes_mutated_in__1_of_individuals">Table 2a</xref>, <xref ref-type="table" rid="rws.T.genes_mutated_in__1_of_individuals_1">Table 2b</xref>) associated with LQTS have symptoms [<xref ref-type="bibr" rid="rws.REF.vincent.1992.846">Vincent et al 1992</xref>, <xref ref-type="bibr" rid="rws.REF.zareba.1998.960">Zareba et al 1998</xref>]. The number of syncopal events in symptomatic individuals ranges from one to hundreds, averaging just a few.</p>
          <p>Pathogenic variants in <italic toggle="yes">KCNQ1</italic>, <italic toggle="yes">KCNH2</italic>, and <italic toggle="yes">SCN5A</italic> account for the vast majority of cases of LQTS and distinct genotype-phenotype correlations have been reported (see <xref ref-type="table" rid="rws.T.genotypephenotype_correlations">Table 3</xref>). Three clinical phenotypes are recognized in individuals with pathogenic variants in these genes.</p>
          <p>QTc range is similar across phenotypes (~400-600+ msec). The average QTc values are similar for the LQTS type 1 and LQTS type 2 phenotypes and somewhat longer for the LQTS type 3 phenotype.</p>
          <p>T-wave patterns characteristic for the LQTS type 1, 2, and 3 phenotypes have been reported and can assist in directing molecular genetic testing strategies to identify the gene involved [<xref ref-type="bibr" rid="rws.REF.zhang.2000.2849">Zhang et al 2000</xref>].</p>
          <p>Cardiac events often have genotype-specific triggers [<xref ref-type="bibr" rid="rws.REF.schwartz.2001.89">Schwartz et al 2001</xref>]. In the LQTS type 1 phenotype symptoms are mostly triggered by exercise while in the LQTS type 2 phenotype emotional stress and auditory stimuli trigger events. In the LQTS type 3 phenotype symptoms mostly occur during sleep.</p>
          <table-wrap id="rws.T.genotypephenotype_correlations" position="anchor" orientation="portrait">
            <label>Table 3. </label>
            <caption>
              <p>Genotype-Phenotype Correlations</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_rws.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotype</th>
                  <th id="hd_h_rws.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th id="hd_h_rws.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Average QTc</th>
                  <th id="hd_h_rws.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">ST-T-Wave Morphology</th>
                  <th id="hd_h_rws.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Incidence of Cardiac Events</th>
                  <th id="hd_h_rws.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Cardiac Event Trigger</th>
                  <th id="hd_h_rws.T.genotypephenotype_correlations_1_1_1_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Sudden Death Risk</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">LQTS type 1</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNQ1</italic>
                  </td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">480 msec</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Broad-base T-wave</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">63%</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Exercise, emotion</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">6%-8%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">LQTS type 2</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNH2</italic>
                  </td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Bifid T-waves</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">46%</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Exercise, emotion, sleep</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">6%-8%</td>
                </tr>
                <tr>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">LQTS type 3</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">SCN5A</italic>
                  </td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~490 msec</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Long ST, small T</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">18%</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Sleep</td>
                  <td headers="hd_h_rws.T.genotypephenotype_correlations_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">6%-8%</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p><bold>Age-related risk.</bold> Cardiac events may occur from infancy through middle age but are most common from the pre-teen years through the 20s, with the risk generally diminishing throughout that time period. The usual age range of events differs somewhat for each genotype. Cardiac events are uncommon after age 40 years; when present, they are often triggered by administration of a QT-prolonging drug or hypokalemia or are associated with the LQTS type 3 phenotype.</p>
          <p><bold>Overall risk of cardiac events.</bold> Of individuals who die of complications of LQTS, death is the first sign of the disorder in an estimated 10%-15%. It is difficult to establish numbers on the risk of cardiac events in LQTS since most individuals are treated. Studies from the long QT registry including patients, individuals with a pathogenic variant (mostly treated) and also relatives who died suddenly show a cumulative mortality before the age of 40 years of 6%-8% in the LQTS type 1, type 2, and type 3 phenotypes. In individuals between 0 to 18 years, those with a LQTS type 1, type 2, or type 3 phenotype had a cumulative mortality of 2%, 3%, and 7% respectively. From 19 to 40 years mortality rates were 5%, 7%, and 5% respectively [<xref ref-type="bibr" rid="rws.REF.zareba.1998.960">Zareba et al 1998</xref>, <xref ref-type="bibr" rid="rws.REF.goldenberg.2008.629">Goldenberg et al 2008</xref>]. Although syncopal events are most common in the LQTS type 1 phenotype (63%), followed by the LQTS type 2 phenotype (46%) and LQTS type 3 phenotype (18%), the incidence of death is similar in all three. A study using the family tree mortality rate method studied mortality in large families with LQTS, in times when disease was not known and individuals received no treatment, compared to the normal population. For the LQTS type 1 phenotype, severely increased mortality was shown throughout childhood (ages 1-19 years), for the type 2 phenotype, increased mortality between ages 15 and 39 years was seen, and in the type 3 phenotype, increased mortality between ages 15 and 19 years was seen [<xref ref-type="bibr" rid="rws.REF.nannenberg.2012.183">Nannenberg et al 2012</xref>].</p>
          <p><bold>Non-cardiac features.</bold> Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia.</p>
          <list list-type="bullet">
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="acpp" document-type="chapter">Andersen-Tawil syndrome</related-object> (LQTS type 7) is associated with prolonged QT interval, muscle weakness, and facial dysmorphism.</p>
            </list-item>
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="timothy" document-type="chapter">Timothy syndrome</related-object> (LQTS type 8) is characterized by prolonged QT interval and hand/foot, facial, and neurodevelopmental features.</p>
            </list-item>
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="jln" document-type="chapter">Jervell and Lange-Nielson syndrome</related-object> (JLNS), an LQTS disorder associated with biallelic pathogenic <italic toggle="yes">KCNQ1</italic> or <italic toggle="yes">KCNE1</italic> variants, is associated with profound sensorineural hearing loss.</p>
            </list-item>
          </list>
        </sec>
        <sec id="rws.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Long QT syndrome (LQTS) associated with biallelic pathogenic variants or heterozygosity for pathogenic variants in two different genes (i.e., digenic pathogenic variants) is generally associated with a more severe phenotype with longer QTc interval and a higher incidence of cardiac events [<xref ref-type="bibr" rid="rws.REF.schwartz.2003.1120">Schwartz et al 2003</xref>, <xref ref-type="bibr" rid="rws.REF.westenskow.2004.1834">Westenskow et al 2004</xref>, <xref ref-type="bibr" rid="rws.REF.tester.2005.507">Tester et al 2005</xref>, <xref ref-type="bibr" rid="rws.REF.itoh.2010.1411">Itoh et al 2010</xref>].</p>
          <p>There are no specific genotype-phenotype correlations known other than as noted in <xref ref-type="sec" rid="rws.Clinical_Description">Clinical Description</xref>.</p>
        </sec>
        <sec id="rws.Penetrance">
          <title>Penetrance</title>
          <p>LQTS exhibits reduced penetrance of the ECG changes and symptoms. Overall, approximately 25% of individuals with a pathogenic variant have a normal QTc (defined as &#x0003c;440 msec) on baseline ECG. The percentage of genetically affected individuals with a normal QTc was higher in the LQTS type 1 group (36%) than in the LQTS type 2 group (19%) or the type 3 group (10%) [<xref ref-type="bibr" rid="rws.REF.priori.2003.1866">Priori et al 2003</xref>, <xref ref-type="bibr" rid="rws.REF.goldenberg.2011.51">Goldenberg et al 2011</xref>].</p>
          <p>As noted in <xref ref-type="table" rid="rws.T.genotypephenotype_correlations">Table 3</xref>, penetrance for symptoms is also reduced. At least 37% of individuals with the LQTS type 1 phenotype, 54% with the type 2 phenotype, and 82% with the type 3 phenotype remain asymptomatic.</p>
        </sec>
        <sec id="rws.Nomenclature">
          <title>Nomenclature</title>
          <p>The term &#x0201c;Romano-Ward syndrome&#x0201d; refers to forms of long QT syndrome with a purely cardiac phenotype, inherited in an autosomal dominant manner (LQTS types 1-3, type 5, type 6, and types 9-15).</p>
        </sec>
        <sec id="rws.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of LQTS has been estimated at 1:2000 [<xref ref-type="bibr" rid="rws.REF.schwartz.2009.113">Schwartz et al 2009</xref>].</p>
          <p>LQTS has been identified in all ethnic groups.</p>
        </sec>
      </sec>
      <sec id="rws.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><related-object link-type="booklink" source-id="gene" document-id="brugada" document-type="chapter"><bold>Brugada syndrome</bold></related-object><bold>.</bold> Pathogenic loss-of-function variants in <italic toggle="yes">SCN5A</italic> are associated with cardiac conduction defects including rapid polymorphic ventricular tachycardia/ventricular fibrillation and sudden death.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cav" document-type="chapter"><bold>Caveolinopathies</bold></related-object><bold>.</bold> Pathogenic variants in <italic toggle="yes">CAV3</italic>, the gene encoding caveolin-3, have been associated with sudden infant death syndrome (SIDS) and LQT syndrome (LQTS type 9) [<xref ref-type="bibr" rid="rws.REF.vatta.2006.2104">Vatta et al 2006</xref>, <xref ref-type="bibr" rid="rws.REF.arnestad.2007.361">Arnestad et al 2007</xref>, <xref ref-type="bibr" rid="rws.REF.cronk.2007.161">Cronk et al 2007</xref>]. <italic toggle="yes">CAV3</italic> pathogenic variants cause an increase in late sodium current similar to that seen in the LQTS type 3 phenotype. <italic toggle="yes">CAV3</italic> pathogenic variants are also associated with a range of muscular disease.</p>
        <p><italic toggle="yes">ANK2</italic> pathogenic variants can cause a broad spectrum of clinical cardiac phenotypes, including <related-object link-type="booklink" source-id="gene" document-id="cvt" document-type="chapter">catecholaminergic polymorphic ventricular arrhythmias</related-object>, sinus node dysfunction, and atrial fibrillation [<xref ref-type="bibr" rid="rws.REF.mohler.2003.634">Mohler et al 2003</xref>, <xref ref-type="bibr" rid="rws.REF.mohler.2007.432">Mohler et al 2007</xref>].</p>
      </sec>
      <sec id="rws.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Other causes of QTc interval prolongation</bold> to be considered:</p>
        <list list-type="bullet">
          <list-item>
            <p>QT-prolonging drugs</p>
          </list-item>
          <list-item>
            <p>Hypokalemia</p>
          </list-item>
          <list-item>
            <p>Certain neurologic conditions including subarachnoid bleed</p>
          </list-item>
          <list-item>
            <p>Structural heart disease</p>
          </list-item>
        </list>
        <p><bold>Other causes of syncope or sudden death</bold> to be considered in children and young adults:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sudden infant death syndrome (SIDS), commonly defined as unexpected sudden death within the first year of life. Death during the first year of life in families with LQTS appears to be rare, yet a percent of infants dying of SIDS have been shown to have pathogenic variants in one of the LQTS-related genes [<xref ref-type="bibr" rid="rws.REF.ackerman.2001.2264">Ackerman et al 2001</xref>, <xref ref-type="bibr" rid="rws.REF.schwartz.2001.89">Schwartz et al 2001</xref>, <xref ref-type="bibr" rid="rws.REF.arnestad.2007.361">Arnestad et al 2007</xref>]. While it seems probable that these pathogenic variants were the cause of the SIDS, the association is uncertain, and the frequency of pathogenic variants in SIDS cases has been questioned [<xref ref-type="bibr" rid="rws.REF.wedekind.2006.129">Wedekind et al 2006</xref>].</p>
          </list-item>
          <list-item>
            <p>Vasovagal (neurally mediated) syncope, orthostatic hypotension</p>
          </list-item>
          <list-item>
            <p>Seizures</p>
          </list-item>
          <list-item>
            <p>Familial ventricular fibrillation</p>
          </list-item>
          <list-item>
            <p>Subtle cardiomyopathies (<related-object link-type="booklink" source-id="gene" document-id="hyper-card" document-type="chapter">HCM</related-object>, DCM, ARVC)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="cvt" document-type="chapter">Catecholaminergic polymorphic ventricular tachycardia</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="brugada" document-type="chapter">Brugada syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Anomalous coronary artery</p>
          </list-item>
          <list-item>
            <p>Drug-induced QT prolongation (see drugs at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.crediblemeds.org/">CredibleMeds<sup>&#x000ae;</sup></ext-link>)</p>
          </list-item>
        </list>
      </sec>
      <sec id="rws.Management_1">
        <title>Management</title>
        <sec id="rws.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with LQTS, the main focus in the management of individuals with LQTS is to identify the subset of individuals at high risk for cardiac events. For this risk stratification the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>ECG evaluation.</bold> Individuals with a QTc interval &#x0003e;500 ms are at higher risk for an event; individuals with QTc interval &#x0003e;600 ms are at extremely high risk [<xref ref-type="bibr" rid="rws.REF.priori.2003.1866">Priori et al 2003</xref>, <xref ref-type="bibr" rid="rws.REF.goldenberg.2008.629">Goldenberg et al 2008</xref>] Overt T-wave alternans, especially when present despite proper beta-blocker therapy, is also associated with a higher risk of cardiac events [<xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>]. Individuals with a pathogenic variant who have a normal QTc interval are at low risk [<xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Medical history.</bold> Individuals with syncope or cardiac arrest in the first year of life [<xref ref-type="bibr" rid="rws.REF.schwartz.2009.113">Schwartz et al 2009</xref>, <xref ref-type="bibr" rid="rws.REF.spazzolini.2009.832">Spazzolini et al 2009</xref>] or younger than age seven years [<xref ref-type="bibr" rid="rws.REF.priori.2004.1341">Priori et al 2004</xref>] are at higher risk. These individuals may not be fully protected by pharmacologic treatment. Individuals with arrhythmic events while on proper pharmacologic treatment are also at higher risk [<xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>]. Asymptomatic individuals with pathogenic variants or individuals with prolonged QT intervals who have been asymptomatic at a young age (age &#x0003c;40 years) are at low risk for events later in life, although females remain at risk after age 40 years [<xref ref-type="bibr" rid="rws.REF.locati.1998.2237">Locati et al 1998</xref>].</p>
            </list-item>
            <list-item>
              <p>
                <bold>Medical genetics consultation</bold>
              </p>
            </list-item>
          </list>
        </sec>
        <sec id="rws.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>All symptomatic persons should be treated (see <xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al [2013]</xref>). Complete cessation of symptoms is the goal. Management is focused on the prevention of syncope, cardiac arrest, and sudden death through use of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Beta blockers</bold> are the mainstay of therapy for LQTS, including asymptomatic individuals with prolonged QT intervals and individuals who have a pathogenic variant on molecular testing with a normal QTc interval [<xref ref-type="bibr" rid="rws.REF.priori.2004.1341">Priori et al 2004</xref>, <xref ref-type="bibr" rid="rws.REF.schwartz.2009.113">Schwartz et al 2009</xref>]. Some individuals have symptoms despite the use of beta blockers [<xref ref-type="bibr" rid="rws.REF.moss.2000.616">Moss et al 2000</xref>]. However, a majority of cardiac events that occur in individuals with LQTS type 1 phenotype &#x0201c;on beta-blockers&#x0201d; are not caused by failure of the medication, but in fact by failure to take the medication (non-compliance) and/or the administration of QT-prolonging drugs [<xref ref-type="bibr" rid="rws.REF.vincent.2009.215">Vincent et al 2009</xref>]. It is suspected that the same holds true for individuals with LQTS type 2, but that has not been systematically studied. It is therefore important that:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Inadequate beta blocker dosing is prevented by regular adjustments in growing children with evaluation of the efficacy of dose by assessment of the exercise ECG or ambulatory ECG;</p>
                </list-item>
                <list-item>
                  <p>Beta blockers <bold>are</bold> taken daily, and strategies are in place in case of missed doses;</p>
                </list-item>
                <list-item>
                  <p>QT-prolonging drugs (see <xref ref-type="sec" rid="rws.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</xref>) are <bold>not</bold> administered to persons with LQTS without careful consideration of risk versus benefit by the individual(s) and physician(s).</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Implantable cardioverter-defibrillators (ICDs)</bold> are recommended in individuals with LQTS resuscitated from a cardiac arrest, although children with a LQTS type 1 phenotype with an arrest while not receiving beta blockers can be treated with beta blockers or with left cardiac sympathetic denervation [<xref ref-type="bibr" rid="rws.REF.alexander.2004.72">Alexander et al 2004</xref>, <xref ref-type="bibr" rid="rws.REF.vincent.2009.215">Vincent et al 2009</xref>, <xref ref-type="bibr" rid="rws.REF.jons.2010.783">Jons et al 2010</xref>]. ICDs can be useful for those individuals with beta-blocker-resistant symptoms or a contraindication for beta blocker therapy (severe asthma) [<xref ref-type="bibr" rid="rws.REF.zareba.2003.337">Zareba et al 2003</xref>, <xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Left cardiac sympathetic denervation (LCSD)</bold> is recommended for high-risk patients with LQTS in whom ICD therapy is refused or contraindicated and/or in whom beta blockers are either not effective, not tolerated, not accepted, or contraindicated [<xref ref-type="bibr" rid="rws.REF.schwartz.2004.1826">Schwartz et al 2004</xref>, <xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>]. LCSD can be useful in individuals who experience events while on therapy with beta blockers or ICD [<xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Sodium channel blockers</bold> can be useful as additional pharmacological therapy for individuals with a LQTS type 3 phenotype with a QTc interval &#x0003e;500 ms in whom this additional compound is shown to shorten the QTc interval by &#x0003e;40 ms [<xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="rws.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p><bold>Beta blockers.</bold> Beta blockers are clinically indicated in all asymptomatic individuals, including those who have a pathogenic variant on molecular testing with a normal QTc interval [<xref ref-type="bibr" rid="rws.REF.priori.2004.1341">Priori et al 2004</xref>, <xref ref-type="bibr" rid="rws.REF.schwartz.2009.113">Schwartz et al 2009</xref>]. Males who have a pathogenic variant and who have been asymptomatic before 40 years are at low risk of cardiac events. In these individuals the necessity of beta-blockers can be discussed [<xref ref-type="bibr" rid="rws.REF.locati.1998.2237">Locati et al 1998</xref>].</p>
          <p><bold>ICD.</bold> In general, ICD implantation is <bold>not</bold> indicated for asymptomatic individuals with LQTS who have not been tried on beta blocker therapy. Prophylactic ICD therapy can be considered for asymptomatic individuals suspected to be at very high risk, such as asymptomatic individuals with two or more pathogenic variants on molecular testing [<xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>]. LQTS-related sudden death in a close relative is not an indication for an ICD in surviving relatives [<xref ref-type="bibr" rid="rws.REF.kaufman.2008.831">Kaufman et al 2008</xref>].</p>
        </sec>
        <sec id="rws.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Examine the past medical history for asthma, orthostatic hypotension, depression, and diabetes mellitus because these disorders may be exacerbated by treatment with beta blockers.</p>
          <p>Although the incidence of arrhythmias during elective interventions such as surgery, endoscopies, childbirth, or dental work is low, it is prudent to monitor the ECG during such interventions and to alert the appropriate medical personnel in case intervention is needed.</p>
        </sec>
        <sec id="rws.Surveillance">
          <title>Surveillance</title>
          <p>Beta-blocker dose should be regularly assessed for efficacy and adverse effects; doses should be altered as needed. Dose adjustment including efficacy testing is especially important in growing children.</p>
          <p>Individuals with an ICD implanted should have regular, periodic evaluations of ICDs for inappropriate shocks and pocket or lead complications.</p>
        </sec>
        <sec id="rws.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Drugs that cause further prolongation of the QT interval or provoke <italic toggle="yes">torsade de pointes</italic> should be avoided for all individuals with LQTS. See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.crediblemeds.org/new-drug-list/">CredibleMeds<sup>&#x000ae;</sup></ext-link> (free registration required) for a complete and updated list. Epinephrine given as part of local anesthetics can trigger arrhythmias and is best avoided.</p>
          <p>Since electrolyte imbalances may also lengthen the QTc interval, identification and correction of electrolyte abnormalities is important. These imbalances can occur as a result of diarrhea, vomiting, metabolic conditions, and imbalanced diets for weight loss.</p>
          <p>Lifestyle modifications are advised based on genotype. For individuals with LQTS type 1 phenotype avoidance of strenuous exercise &#x02013; especially swimming without supervision &#x02013; is advised. In individuals with LQTS type 2 phenotype reduction in exposure to loud noises such as alarm clocks and phone ringing is advised. In individuals at high risk for cardiac events or with exercise-induced symptoms competitive sport should be avoided [<xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>]. For some individuals participation in competitive sports may be safe. It is therefore recommended that all individuals with LQTS who wish to engage in competitive sports have their risk evaluated by a clinical expert [<xref ref-type="bibr" rid="rws.REF.johnson.2012.764">Johnson &#x00026; Ackerman 2012</xref>, <xref ref-type="bibr" rid="rws.REF.priori.2013.1932">Priori et al 2013</xref>].</p>
        </sec>
        <sec id="rws.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Presymptomatic diagnosis of at-risk relatives followed by treatment is necessary to prevent syncope and sudden death in those individuals who have inherited the pathogenic variant and/or have ECG findings consistent with LQTS. At-risk family members should be alerted to their risk and the need to be evaluated.</p>
          <p>Relatives at high potential risk for LQTS who require further testing include members of a family:</p>
          <list list-type="bullet">
            <list-item>
              <p>That has documented LQTS;</p>
            </list-item>
            <list-item>
              <p>In which evaluation for LQTS has not been performed.</p>
            </list-item>
          </list>
          <p>Presymptomatic diagnosis for at-risk asymptomatic family members can be performed by <bold>one</bold>
<bold>or both</bold> of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing if the pathogenic variant in the family is known</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant is not known or if genetic testing is not possible, QTc analysis on resting and in case of normal QTc also QTc analysis on exercise ECGsNote: The diagnostic accuracy by QTc analysis is considerably improved by evaluation of the exercise ECG QTc intervals, in addition to the resting ECG, using the QTc values listed in <xref ref-type="table" rid="rws.T.scoring_system_for_clinical_diagno">Table 1</xref>.</p>
            </list-item>
          </list>
          <p>Relatives at low potential risk who do not require further testing include members of a family in which the connecting ancestor:</p>
          <list list-type="bullet">
            <list-item>
              <p>Has a low probability of LQTS based on QTc interval (see <xref ref-type="table" rid="rws.T.scoring_system_for_clinical_diagno">Table 1</xref>) and has not experienced LQTS-type events; or</p>
            </list-item>
            <list-item>
              <p>Has a normal QTc interval and no evidence of a pathogenic variant in one of the genes known to cause LQTS; or</p>
            </list-item>
            <list-item>
              <p>Does not have the family-specific pathogenic variant, if known.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="rws.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="rws.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>The post-partum period is associated with increased risk for a cardiac event, especially in individuals with the LQTS type 2 phenotype. Beta blocker treatment was associated with a reduction of events in this nine-month time period after delivery [<xref ref-type="bibr" rid="rws.REF.seth.2007.1092">Seth et al 2007</xref>].</p>
        </sec>
        <sec id="rws.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Gene-specific therapies (mostly for LQTS type 3 phenotype) have been investigated, especially in individuals with cardiac events despite beta blocker, ICD, or LCSD therapy. Examples are mexiletine [<xref ref-type="bibr" rid="rws.REF.schwartz.1995.3381">Schwartz et al 1995</xref>], flecainide [<xref ref-type="bibr" rid="rws.REF.moss.2005.59">Moss et al 2005</xref>], and ranolazine [<xref ref-type="bibr" rid="rws.REF.moss.2008.1289">Moss et al 2008</xref>]. Follow-up experience with these drugs is still limited.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="rws.Other">
          <title>Other</title>
          <p>Most affected individuals live normal lifestyles. Education of adult individuals and the parents of affected children, especially about beta blocker compliance, is an important aspect of management.</p>
        </sec>
      </sec>
      <sec id="rws.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="rws.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Long QT syndrome (LQTS) is typically inherited in an autosomal dominant manner.</p>
          <p>LQTS with extracardiac signs can be inherited in an autosomal dominant or autosomal recessive manner. <related-object link-type="booklink" source-id="gene" document-id="timothy" document-type="chapter">Timothy syndrome</related-object> and <related-object link-type="booklink" source-id="gene" document-id="acpp" document-type="chapter">Andersen-Tawil syndrome</related-object> are inherited in an autosomal dominant manner. Jervell and Lange-Nielsen syndrome is inherited in an autosomal recessive manner (see <related-object source-id="gene" document-id="jln" object-id="jln.Genetic_Counseling">Jervell and Lange-Nielsen Syndrome, Genetic Counseling</related-object> for discussion of autosomal recessive inheritance and genetic counseling for this disorder).</p>
        </sec>
        <sec id="rws.Risk_to_Family_Members__Autosomal_Do">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The majority of individuals diagnosed with LQTS have inherited a pathogenic variant from a parent.</p>
            </list-item>
            <list-item>
              <p>A proband with LQTS may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is small.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant identified in the proband cannot be detected in the DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband.</p>
            </list-item>
            <list-item>
              <p>If the parent from whom the proband inherited a pathogenic variant cannot be determined on the basis of clinical and family history, molecular genetic testing should be offered to both parents to identify which one has the pathogenic variant identified in the proband.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with LQTS may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or reduced penetrance. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or molecular genetic testing has been performed on the parents of the proband (see Management, <xref ref-type="sec" rid="rws.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref>).</p>
            </list-item>
          </list>
          <p>Note: Biallelic and digenic pathogenic variants been described (see <xref ref-type="sec" rid="rws.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>). If an individual with LQTS has biallelic or digenic pathogenic variants, the possibility that both parents have pathogenic variants should be considered.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband has a pathogenic variant, the risk to the sibs of inheriting the pathogenic variant is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected and the pathogenic variant is not known in the family, the risk to the sibs of a proband is increased, but cannot be accurately estimated.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with LQTS has a 50% chance of inheriting the pathogenic variant.</p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is clinically affected or has a pathogenic variant, his or her family members are at risk.</p>
            </list-item>
          </list>
          <p><bold>Specific risk issues.</bold> With the reduced penetrance of symptoms in individuals with LQTS, careful ECG evaluation, including exercise ECG, is often necessary to identify affected family members accurately. The absence of a family history of sudden death is common and does not negate the diagnosis or preclude the possibility of sudden death in relatives.</p>
        </sec>
        <sec id="rws.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Testing of at-risk asymptomatic adults and children.</bold> Testing of at-risk asymptomatic adults for LQTS is possible using the techniques described in Diagnosis, <xref ref-type="sec" rid="rws.Establishing_the_Diagnosis">Establishing the Diagnosis</xref>. Such testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. To facilitate the use of morbidity- and mortality-reducing interventions, presymptomatic testing of all at-risk family members, especially including individuals younger than age 18 years because risk of cardiac events is greatest in childhood, should be considered (see Management, <xref ref-type="sec" rid="rws.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref>). When testing at-risk individuals for LQTS, an affected family member should be tested first to identify the pathogenic variant in the family. If no pathogenic variant is identified in an affected family member (the case in ~20% of families with LQTS) [<xref ref-type="bibr" rid="rws.REF.ackerman.2011.1308">Ackerman et al 2011</xref>], at-risk relatives should undergo careful clinical examination.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="rws.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If a pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of the gene of interest or custom prenatal testing.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="rws.Resources">
        <title>Resources</title>
      </sec>
      <sec id="rws.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="rws.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The genes associated with LQTS encode for potassium or sodium cardiac ion channels or interacting proteins. Pathogenic variants in these genes cause abnormal ion channel function: a loss of function in the potassium channels and a gain of function in the sodium channel. This abnormal ion function results in prolongation of the cardiac action potential and susceptibility of the cardiac myocytes to early after depolarizations (EADs), which initiate the ventricular arrhythmia, <italic toggle="yes">torsade de pointes</italic> (TdP).</p>
          <p>For a detailed summary of gene and protein information for the genes listed below, see <related-object source-id="gene" document-id="rws" object-id="rws.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <sec id="rws.KCNQ1">
            <title>
              <italic toggle="yes">KCNQ1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNQ1</italic> spans approximately 400 kb. The predominant isoform (isoform 1, refseq <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000218">NM_000218.2</ext-link>) consists of 16 exons and produces a protein of 676 amino acids. Other isoforms, encoding a protein with an alternative N terminal domain (isoform 2) or non-coding transcripts exist.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 500 pathogenic variants of <italic toggle="yes">KCNQ1</italic> have been reported, including pathogenic missense, nonsense, splice site, and frameshift variants as well as large multiexon deletions (see <xref ref-type="sec" rid="rws.Note">Note</xref>).</p>
            <p><bold>Normal gene product.</bold> The potassium voltage-gated channel subfamily KQT member 1 is the alpha subunit forming the slowly activating potassium delayed rectifier IKs [<xref ref-type="bibr" rid="rws.REF.keating.2001.569">Keating &#x00026; Sanguinetti 2001</xref>].</p>
            <p><bold>Abnormal gene product.</bold> IKs channel with reduced function</p>
          </sec>
          <sec id="rws.KCNH2">
            <title>
              <italic toggle="yes">KCNH2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNH2</italic> spans approximately 19 kb. The longest isoform consists of 16 exons and produces a protein of 1159 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000238">NM_000238.3</ext-link>). Two shorter isoforms of <italic toggle="yes">KCNH2</italic> exist.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 700 pathogenic variants have been reported, including pathogenic missense, nonsense, splice site and frameshift variants as well as large multiexon deletions (see <xref ref-type="sec" rid="rws.Note">Note</xref>).</p>
            <p><bold>Normal gene product.</bold> The potassium voltage-gated channel subfamily H member 2 is the alpha subunit forming the rapidly activating potassium delayed rectifier Ikr.</p>
            <p><bold>Abnormal gene product.</bold> IKr channel with reduced function</p>
          </sec>
          <sec id="rws.SCN5A">
            <title>
              <italic toggle="yes">SCN5A</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">SCN5A</italic> consists of 28 exons, spans approximately 80 kb; it encodes a protein of 2016 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_198056.2">NM_198056.2</ext-link>). An isoform lacking amino acid Gln1077 exists.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 200 pathogenic variants are known; they include pathogenic missense variants and in-frame deletions or insertions.</p>
            <p><bold>Normal gene product.</bold> The sodium channel protein type V alpha subunit is the alpha subunit forming the cardiac sodium channel.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic gain-of-function variant resulting in a cardiac sodium channel with increased persistent inward current</p>
          </sec>
          <sec id="rws.ANK2">
            <title>
              <italic toggle="yes">ANK2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">ANK2</italic> consists of 46 exons spanning approximately 350 kb; it encodes a protein of 3957 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000890.3">NM_001148.4</ext-link>). Alternative spliced variants exist.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 20 pathogenic variants in <italic toggle="yes">ANK2,</italic> associated with LQTS, have been described.</p>
            <p><bold>Normal gene product.</bold> Ankyrin 2, neuronal is required for targeting and stability of Na/Ca exchanger 1, Na/K ATPase, and InsP3 receptor in cardiomyocytes.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic loss-of-function variant resulting in disturbed coordination of multiple functionally related ion channels and transporters</p>
          </sec>
          <sec id="rws.KCNE1">
            <title>
              <italic toggle="yes">KCNE1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNE1</italic> consists of three exons spanning approximately 40 kb, it encodes a protein of 129 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000219.3">NM_000219.3</ext-link>).</p>
            <p><bold>Pathogenic allelic variants.</bold> At least 36 pathogenic variants have been described, including pathogenic missense, nonsense, and frameshift variants (see <xref ref-type="sec" rid="rws.Note">Note</xref>).</p>
            <p><bold>Normal gene product.</bold> The potassium voltage-gated channel subfamily E member 1 is the beta subunit forming the slowly activating potassium delayed rectifier IKs. The two subunits encoded by <italic toggle="yes">KCNE1</italic> and <italic toggle="yes">KCNQ1</italic> coassemble to form the IKs channel.</p>
            <p><bold>Abnormal gene product.</bold> IKs channel with reduced function</p>
          </sec>
          <sec id="rws.KCNE2">
            <title>
              <italic toggle="yes">KCNE2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNE2</italic> consists of three exons spanning approximately 40 kb; it encodes a protein of 123 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_172201.1">NM_172201.1</ext-link>).</p>
            <p><bold>Pathogenic allelic variants.</bold> At least 20 pathogenic variants have been reported; they include missense and frameshift variants (see <xref ref-type="sec" rid="rws.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>).</p>
            <p><bold>Normal gene product.</bold> The potassium voltage-gated channel subfamily E member 2 is the beta subunit forming the rapidly activating potassium delayed rectifier IKr. The two subunits encoded by <italic toggle="yes">KCNH2</italic> and <italic toggle="yes">KCNE2</italic> coassemble to form the IKr channel.</p>
            <p><bold>Abnormal gene product.</bold> IKr channel with reduced function</p>
          </sec>
          <sec id="rws.KCNJ2">
            <title>
              <italic toggle="yes">KCNJ2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNJ2</italic> consists of two exons spanning approximately 15 kb; it encodes a protein of 428 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000891.2">NM_000891.2</ext-link>).</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 70 pathogenic variants in <italic toggle="yes">KCNJ2</italic> associated with long QT/Andersen-Tawil syndrome have been described.</p>
            <p><bold>Normal gene product.</bold> The potassium channel, inwardly rectifying subfamily J, member 2 is an inward-rectifier type potassium channel (Kir2.1).</p>
            <p><bold>Abnormal gene product.</bold> Dominant negative pathogenic variants resulting in decreased potassium currents</p>
          </sec>
          <sec id="rws.CACNA1C">
            <title>
              <italic toggle="yes">CACNA1C</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CACNA1C</italic> consists of forty-seven exons spanning approximately 650 kb; it encodes a protein of 2138 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000719.6">NM_000719.6</ext-link>). Multiple alternative spliced variants exist.</p>
            <p><bold>Pathogenic allelic variants.</bold> Only a few pathogenic variants in <italic toggle="yes">CACNA1C</italic> associated with long QT/Timothy syndrome have been described.</p>
            <p><bold>Normal gene product.</bold> The calcium channel, voltage-dependent, L type, alpha 1C subunit is the alpha-1 subunit of a cardiac voltage-dependent calcium channel .</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in exons 8 or 8A causing reduced channel inactivation, resulting in maintained depolarizing L-type calcium currents</p>
          </sec>
          <sec id="rws.CAV3">
            <title>
              <italic toggle="yes">CAV3</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CAV3</italic> consists of two exons spanning approximately 12 kb; it encodes a protein of 151 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_033337.2">NM_033337.2</ext-link>).</p>
            <p><bold>Pathogenic allelic variants.</bold> Five probable LQTS-causing missense variants in <italic toggle="yes">CAV3</italic> have been described.</p>
            <p><bold>Normal gene product.</bold> The caveolin-3 protein is the major scaffolding protein present in caveolae in the heart.</p>
            <p><bold>Abnormal gene product.</bold> Persistent late sodium current</p>
          </sec>
          <sec id="rws.SCN4B">
            <title>
              <italic toggle="yes">SCN4B</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">SCN4B</italic> consists of five exons spanning approximately 20 kb; it encodes a protein of 228 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_174934">NM_174934</ext-link>). A shorter isoform exists.</p>
            <p><bold>Pathogenic allelic variants.</bold> Two pathogenic missense variants in <italic toggle="yes">SCN4B</italic> have been associated with LQTS.</p>
            <p><bold>Normal gene product.</bold> The sodium channel protein type IV beta subunit is a beta subunit forming the cardiac sodium channel.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic loss-of-function variant resulting in a cardiac sodium channel with increased persistent inward current</p>
          </sec>
          <sec id="rws.AKAP9">
            <title>
              <italic toggle="yes">AKAP9</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">AKAP9</italic> consists of 50 exons and encodes a protein of 3907 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_005751.4">NM_005751.4</ext-link>). A shorter isoform exists.</p>
            <p><bold>Pathogenic allelic variants.</bold> One pathogenic missense variant in <italic toggle="yes">AKAP9</italic> associated with LQTS has been described.</p>
            <p><bold>Normal gene product.</bold> The A kinase (prka) anchor protein (yotiao) 9 is involved in macromolecular complexes controlling phosphorylation of a number of proteins, including the Iks channel.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic loss-of-function variant resulting in an IKs channel with reduced function</p>
          </sec>
          <sec id="rws.SNTA1">
            <title>
              <italic toggle="yes">SNTA1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">SNTA1</italic> consists of eight exons spanning approximately 35 kb; it encodes a protein of 505 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003098.2">NM_003098.2</ext-link>).</p>
            <p><bold>Pathogenic allelic variants.</bold> Three pathogenic missense variants in <italic toggle="yes">SNTA1</italic> associated with LQTS have been described.</p>
            <p><bold>Normal gene product.</bold> The alpha-1 syntrophin is a scaffolding protein involved in macromolecular complexes controlling the function of, among others, the cardiac sodium channel.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic loss-of-function variant resulting in a cardiac sodium channel with increased persistent inward current</p>
          </sec>
          <sec id="rws.KCNJ5">
            <title>
              <italic toggle="yes">KCNJ5</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNJ5</italic> consists of three exons spanning approximately 30 kb; it encodes a protein of 419 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000890.3">NM_000890.3</ext-link>).</p>
            <p><bold>Pathogenic allelic variants.</bold> Two pathogenic missense variants in <italic toggle="yes">KCNJ5</italic> associated with LQTS have been described.</p>
            <p><bold>Normal gene product.</bold> The potassium inwardly-rectifying channel, subfamily J, member 5 is a subunit of the cardiac inwardly rectifying potassium channel IKACh.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic loss-of-function variant resulting in an IKACh channel with reduced function</p>
          </sec>
          <sec id="rws.CALM1">
            <title>
              <italic toggle="yes">CALM1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CALM1</italic> consists of six exons spanning approximately 11 kb; it encodes a protein of 149 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006888.4">NM_006888.4</ext-link>).</p>
            <p><bold>Pathogenic allelic variants.</bold> Only a few pathogenic variants in <italic toggle="yes">CALM1</italic> have been described.</p>
            <p><bold>Normal gene product.</bold> Calmodulin 1 is a calcium-modulated protein regulating L-type calcium channel function.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">CALM1</italic> result in several-fold reduction in calcium-binding affinity.</p>
          </sec>
          <sec id="rws.CALM2">
            <title>
              <italic toggle="yes">CALM2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CALM2</italic> consists of six exons spanning approximately 16 kb; it encodes a protein of 149 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001743.4">NM_001743.4</ext-link>).</p>
            <p><bold>Pathogenic allelic variants.</bold> Only a few pathogenic variants in <italic toggle="yes">CALM2</italic> have been described.</p>
            <p><bold>Normal gene product.</bold> Calmodulin 2 is a calcium-modulated protein regulating L-type calcium channel function.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">CALM2</italic> result in several-fold reduction in calcium-binding affinity.</p>
          </sec>
          <sec id="rws.Note">
            <title>Note</title>
            <p>More than 1400 pathogenic variants in the 15 LQTS-related genes have been reported and are listed in the various databases found in <related-object source-id="gene" document-id="rws" object-id="rws.molgen.TA">Table A</related-object>. In general, approximately 70% of pathogenic variants reported are missense, 15% are frameshift, and in-frame deletions, nonsense, and splice site variants make up 3%-6% each. However, this distribution varies by gene. Radical pathogenic variants such as frameshift, nonsense, and splice site types are relatively more frequent in <italic toggle="yes">KCNQ1</italic> and <italic toggle="yes">KCNH2</italic> and are not present in <italic toggle="yes">SCN5A</italic> in individuals with LQTS (such pathogenic variants in <italic toggle="yes">SCN5A</italic> cause <related-object link-type="booklink" source-id="gene" document-id="brugada" document-type="chapter">Brugada syndrome</related-object> rather than LQTS).</p>
          </sec>
        </sec>
      </sec>
      <sec id="rws.References">
        <title>References</title>
        <sec id="rws.Published_GuidelinesConsensus_Statem">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="rws.Published_GuidelinesConsensus_Statem.reflist0">
            <ref id="rws.REF1">
              <mixed-citation publication-type="webpage">American College of Cardiology/American Heart Association Task Force, and the European Society of Cardiology/Committee for Practice Guidelines. Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://circ.ahajournals.org/content/114/10/1088.full.pdf+html">online</ext-link>. 2006. Accessed 9-4-15.</mixed-citation>
            </ref>
            <ref id="rws.REF.vincent.2001">
              <mixed-citation publication-type="webpage">Vincent GM. Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome. Heart. 86:12-4. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1729812/pdf/v086p00012.pdf">online</ext-link>. 2001. Accessed 9-4-15.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="rws.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="rws.Literature_Cited.reflist0">
            <ref id="rws.REF.ackerman.2002.413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khositseth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tester</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejlik</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>CB</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome.</article-title>
                <source>Mayo Clin Proc</source>
                <volume>77</volume>
                <fpage>413</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">12004990</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.ackerman.2011.1308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willems</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berul</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brugada</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calkins</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camm</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellinor</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gollob</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Judge</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marec</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenna</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze-Bahr</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semsarian</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolpert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zipes</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).</article-title>
                <source>Heart Rhythm</source>
                <volume>8</volume>
                <fpage>1308</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">21787999</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.ackerman.2001.2264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siu</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sturner</surname>
                    <given-names>WQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tester</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valdivia</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makielski</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.</article-title>
                <source>JAMA</source>
                <volume>286</volume>
                <fpage>2264</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11710892</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.alexander.2004.72">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alexander</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cecchin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Triedman</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bevilacqua</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berul</surname>
                    <given-names>CI</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.</article-title>
                <source>J Cardiovasc Electrophysiol.</source>
                <year>2004</year>
                <volume>15</volume>
                <fpage>72</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15028076</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.arnestad.2007.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arnestad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crotti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rognum</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Insolia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedrazzini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrandi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vege</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhodes</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>AL</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Prevalence of long-QT syndrome gene variants in sudden infant death syndrome.</article-title>
                <source>Circulation.</source>
                <volume>115</volume>
                <fpage>361</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17210839</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.barc.2011.40">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barc</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briec</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyndt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Cunff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieyres</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacher</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Caignec</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marec</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Probst</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schott</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.</article-title>
                <source>J Am Coll Cardiol.</source>
                <year>2011</year>
                <volume>57</volume>
                <fpage>40</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21185499</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.cronk.2007.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cronk</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaku</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tester</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vatta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makielski</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3.</article-title>
                <source>Heart Rhythm</source>
                <volume>4</volume>
                <fpage>161</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17275750</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.goldenberg.2011.51">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horr</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopes</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barsheshet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locati</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhorin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Platonov</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals.</article-title>
                <source>J Am Coll Cardiol.</source>
                <year>2011</year>
                <volume>57</volume>
                <fpage>51</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21185501</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.goldenberg.2008.629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Long</surname>
                    <given-names>QT</given-names>
                  </name>
                </person-group>
                <article-title>Syndrome.</article-title>
                <source>Curr Probl Cardiol.</source>
                <year>2008</year>
                <volume>33</volume>
                <fpage>629</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">18835466</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.horner.2011.1698">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horner</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horner</surname>
                    <given-names>MM.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackermann</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome.</article-title>
                <source>Heart Rhythm</source>
                <volume>8</volume>
                <fpage>1698</fpage>
                <lpage>704</lpage>
                <pub-id pub-id-type="pmid">21699858</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.itoh.2010.1411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamagata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakaguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makiyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akao</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyazaki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamagishi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamakura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horie</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study.</article-title>
                <source>Heart Rhythm.</source>
                <year>2010</year>
                <volume>7</volume>
                <fpage>1411</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20541041</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.jervell.1957.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jervell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lange-Nielsen</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1957</year>
                <article-title>Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death.</article-title>
                <source>Am Heart J</source>
                <volume>54</volume>
                <fpage>59</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">13435203</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.johnson.2012.764">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Competitive sports participation in athletes with congenital long QT syndrome</article-title>
                <source>JAMA</source>
                <volume>308</volume>
                <fpage>764</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22820673</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.jons.2010.783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Risk of fatal arrhythmic events in long QT syndrome patients after syncope.</article-title>
                <source>J Am Coll Cardiol</source>
                <volume>55</volume>
                <fpage>783</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20170817</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.kapa.2009.1752">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kapa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tester</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salisbury</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris-Kerr</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pungliya</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alders</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.</article-title>
                <source>Circulation.</source>
                <volume>120</volume>
                <fpage>1752</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">19841300</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.kapplinger.2009.1297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kapplinger</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tester</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salisbury</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris-Kerr</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollevick</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.</article-title>
                <source>Heart Rhythm.</source>
                <year>2009</year>
                <volume>6</volume>
                <fpage>1297</fpage>
                <lpage>303</lpage>
                <pub-id pub-id-type="pmid">19716085</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.kaufman.2008.831">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhorin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locati</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Risk of death in the long QT syndrome when a sibling has died.</article-title>
                <source>Heart Rhythm</source>
                <volume>5</volume>
                <fpage>831</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18534367</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.keating.2001.569">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanguinetti</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Molecular and cellular mechanisms of cardiac arrhythmias.</article-title>
                <source>Cell</source>
                <volume>104</volume>
                <fpage>569</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">11239413</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.locati.1998.2237">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Locati</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>WJ</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry.</article-title>
                <source>Circulation</source>
                <volume>97</volume>
                <fpage>2237</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">9631873</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.mohler.2007.432">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mohler</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Scouarnec</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denjoy</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lowe</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caron</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Driskell</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schott</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norris</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leenhardt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escande</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roden</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.</article-title>
                <source>Circulation.</source>
                <volume>115</volume>
                <fpage>432</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">17242276</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.mohler.2003.634">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mohler</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schott</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gramolini</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dilly</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guatimosim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>duBell</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haurogne</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyndt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lederer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escande</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marec</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.</article-title>
                <source>Nature</source>
                <volume>421</volume>
                <fpage>634</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12571597</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.moss.2005.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Windle</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Severski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daubert</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cieciorka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manalan</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.</article-title>
                <source>Ann Noninvasive Electrocardiol.</source>
                <volume>10</volume>
                <fpage>59</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">16274417</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.moss.2000.616">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crampton</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhorin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locati</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.</article-title>
                <source>Circulation</source>
                <volume>101</volume>
                <fpage>616</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">10673253</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.moss.2008.1289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarz</surname>
                    <given-names>KQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.</article-title>
                <source>J Cardiovasc Electrophysiol</source>
                <volume>19</volume>
                <fpage>1289</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">18662191</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.nannenberg.2012.183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nannenberg</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sijbrands</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dijksman</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alders</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Tintelen</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birnie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Langen</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Mortality of inherited arrhythmia syndromes: insight into their natural history.</article-title>
                <source>Circ Cardiovasc Genet.</source>
                <volume>5</volume>
                <fpage>183</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22373669</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.napolitano.2005.2975">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bloise</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronchetti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nastoli</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerrone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonardi</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice.</article-title>
                <source>JAMA</source>
                <volume>294</volume>
                <fpage>2975</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">16414944</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.priori.2004.1341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grillo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bloise</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronchetti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moncalvo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tulipani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nastoli</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.</article-title>
                <source>JAMA</source>
                <year>2004</year>
                <volume>292</volume>
                <fpage>1341</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15367556</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.priori.2003.1866">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bloise</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronchetti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grillo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicentini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spazzolini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nastoli</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Folli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappelletti</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Risk stratification in the long-QT syndrome.</article-title>
                <source>N Engl J Med.</source>
                <year>2003</year>
                <volume>348</volume>
                <fpage>1866</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">12736279</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.priori.2013.1932">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Behr</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berul</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brugada</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiang</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huikuri</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannankeril</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leenhardt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomaselli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tracy</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.</article-title>
                <source>Heart Rhythm.</source>
                <year>2013</year>
                <volume>10</volume>
                <fpage>1932</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">24011539</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.schwartz.2011.2181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crotti</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>QTc behavior during exercise and genetic testing for the long-QT syndrome.</article-title>
                <source>Circulation.</source>
                <volume>124</volume>
                <fpage>2181</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22083145</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.schwartz.1993.782">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crampton</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Diagnostic criteria for the long QT syndrome. An update.</article-title>
                <source>Circulation.</source>
                <volume>88</volume>
                <fpage>782</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8339437</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.schwartz.2004.1826">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerrone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spazzolini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odero</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bloise</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Ferrari</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klersy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brink</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toivonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Epstein</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.</article-title>
                <source>Circulation</source>
                <volume>109</volume>
                <fpage>1826</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">15051644</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.schwartz.1995.3381">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locati</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant&#x000f9;</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammoude</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.</article-title>
                <source>Circulation</source>
                <volume>92</volume>
                <fpage>3381</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8521555</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.schwartz.2003.1120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>How really rare are rare diseases?</article-title>
                <source>J Cardiovasc Electrophysiol.</source>
                <volume>14</volume>
                <fpage>1120</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">14521668</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.schwartz.2001.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spazzolini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denjoy</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breithardt</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brink</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toivonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corfield</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wattanasirichaigoon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haverkamp</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze-Bahr</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coumel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bloise</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.</article-title>
                <source>Circulation</source>
                <volume>103</volume>
                <fpage>89</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">11136691</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.schwartz.2009.113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spazzolini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crotti</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>All LQT3 patients need an ICD: true or false?</article-title>
                <source>Heart Rhythm</source>
                <volume>6</volume>
                <fpage>113</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">19121811</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.seth.2007.1092">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seth</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhorin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locati</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Long QT syndrome and pregnancy.</article-title>
                <source>J Am Coll Cardiol.</source>
                <volume>49</volume>
                <fpage>1092</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17349890</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.shimizu.2004.276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagaya</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satomi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aihara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunagawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echigo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimasa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamakura</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome.</article-title>
                <source>Heart Rhythm</source>
                <volume>1</volume>
                <fpage>276</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">15851169</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.spazzolini.2009.832">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spazzolini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullally</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouellet</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fugate</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhorin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crotti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locati</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy.</article-title>
                <source>J Am Coll Cardiol.</source>
                <volume>54</volume>
                <fpage>832</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19695463</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.splawski.2000.1178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Splawski</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.</article-title>
                <source>Circulation</source>
                <volume>102</volume>
                <fpage>1178</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">10973849</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.swan.1998.508">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toivonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viitasalo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Rate adaptation of QT intervals during and after exercise in children with congenital long QT syndrome.</article-title>
                <source>Eur Heart J</source>
                <volume>19</volume>
                <fpage>508</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">9568456</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.sy.2011.2187">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sy</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Werf</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chattha</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chockalingam</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healey</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gollob</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skanes</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yee</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gula</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leong-Sit</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viskin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <article-title>Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands.</article-title>
                <source>Circulation.</source>
                <year>2011</year>
                <volume>124</volume>
                <fpage>2187</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">22042885</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.tester.2005.507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tester</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Will</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haglund</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.</article-title>
                <source>Heart Rhythm</source>
                <volume>2</volume>
                <fpage>507</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">15840476</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.van_langen.2003.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Langen</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birnie</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alders</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jongbloed</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marec</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>141</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12566525</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.vatta.2006.2104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vatta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makielski</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ughanze</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tester</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balijepalli</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foell</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamp</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.</article-title>
                <source>Circulation.</source>
                <year>2006</year>
                <volume>114</volume>
                <fpage>2104</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">17060380</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.vincent.1991.498">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaiswal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Effects of exercise on heart rate, QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome.</article-title>
                <source>Am J Cardiol</source>
                <volume>68</volume>
                <fpage>498</fpage>
                <lpage>503</lpage>
                <pub-id pub-id-type="pmid">1872278</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.vincent.2009.215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denjoy</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bithell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spazzolini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crotti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piippo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupoglazoff</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villain</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>High efficacy of beta-blockers in long-QT syndrome type1; contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment &#x0201c;failures&#x0201d;.</article-title>
                <source>Circulation</source>
                <volume>119</volume>
                <fpage>215</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">19118258</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.vincent.1992.846">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome.</article-title>
                <source>N Engl J Med</source>
                <volume>327</volume>
                <fpage>846</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">1508244</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.viskin.2010.1955">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Viskin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Postema</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhuiyan</surname>
                    <given-names>ZA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosso</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vohra</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guevara-Valdivia</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquez</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kogan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belhassen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glikson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strasberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antzelevitch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AAM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The response of the QT interval to the brief tachycardia provoked by standing a bedside test for diagnosing long QT syndrome.</article-title>
                <source>JACC</source>
                <volume>55</volume>
                <fpage>1955</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">20116193</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.vyas.2006.1385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vyas</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejlik</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response.</article-title>
                <source>Circulation.</source>
                <year>2006</year>
                <volume>113</volume>
                <fpage>1385</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">16534005</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.wedekind.2006.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wedekind</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bajanowski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friederich</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breithardt</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>W&#x000fc;lfing</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebrands</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engeland</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;nnig</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haverkamp</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brinkmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze-Bahr</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study.</article-title>
                <source>Int J Legal Med.</source>
                <volume>120</volume>
                <fpage>129</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">16012827</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.westenskow.2004.1834">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Westenskow</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Splawski</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanguinetti</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Compound mutations: a common cause of severe long-QT syndrome.</article-title>
                <source>Circulation.</source>
                <year>2004</year>
                <volume>109</volume>
                <fpage>1834</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">15051636</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.zareba.2003.337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daubert</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Implantable cardioverter defibrillator in high-risk long QT syndrome patients.</article-title>
                <source>J Cardiovasc Electrophysiol</source>
                <volume>14</volume>
                <fpage>337</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">12741701</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.zareba.1998.960">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhorin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locati</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>WJ</given-names>
                  </name>
                </person-group>
                <article-title>Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.</article-title>
                <source>N Engl J Med.</source>
                <year>1998</year>
                <volume>339</volume>
                <fpage>960</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9753711</pub-id>
              </element-citation>
            </ref>
            <ref id="rws.REF.zhang.2000.2849">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuli</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Splawski</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Compton</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanowitz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhorin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medina</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes.</article-title>
                <source>Circulation</source>
                <volume>102</volume>
                <fpage>2849</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">11104743</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="rws.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="rws.Author_History">
          <title>Author History</title>
          <p>Mari&#x000eb;lle Alders, PhD (2012-present)Imke Christiaans, PhD, MD (2015-present)Marcel MAM Mannens, PhD; University of Amsterdam (2012-2015)G Michael Vincent, MD; University of Utah School of Medicine (2003-2012)</p>
        </sec>
        <sec id="rws.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>18 June 2015 (me) Comprehensive update posted live (title change)</p>
            </list-item>
            <list-item>
              <p>31 May 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 August 2009 (cd) Revision: prenatal diagnosis available for LQT1, LQT2, LQT3, LQT5, LQT6</p>
            </list-item>
            <list-item>
              <p>7 May 2009 (gmv) Revision: deletion/duplication analysis available clinically for LQT2 and LQT3; additions to Management</p>
            </list-item>
            <list-item>
              <p>21 May 2008 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>7 July 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>28 February 2005 (gmv) Revision: sequence analysis clinically available; LQt4 moved to Differential Diagnosis</p>
            </list-item>
            <list-item>
              <p>13 April 2004 (cd) Revision: <italic toggle="yes">ANK2</italic> testing clinically available</p>
            </list-item>
            <list-item>
              <p>11 February 2004 (bp/gmv) Revisions</p>
            </list-item>
            <list-item>
              <p>18 November 2003 (gmv) Revisions</p>
            </list-item>
            <list-item>
              <p>16 June 2003 (gmv) Revision: Table 4</p>
            </list-item>
            <list-item>
              <p>20 February 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>25 October 2002 (gmv) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
